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Abstract: Recent reviews and meta-analyses of the literature over the past quarter-century have failed
to provide enough evidence to prove or disprove the actual utility of photonic therapy in periodontitis,
alone or adjunctive to conventional approaches. This apparent paradox has been explained by
the many physical, molecular, biological, anatomical, and technical variables of photonic treatments,
which can differ in light-emitting devices (laser or LED), wavelengths, irradiation power and modes,
clinical objectives, follow-up times, disease grading, and assessment methods. This multi-faceted,
controversial scenario has led practitioners to underestimate the actual potential of photonic therapy
in periodontal diseases. In this critical appraisal of the literature, we have briefly summarized the main
photonic therapies and instruments used in Periodontology, highlighting their main characteristics
and limitations. Then, we have tried to identify and discuss the key methodological issues which can
have an impact on the outcome of photonic therapies. Our main goal was to identify the best
parameters, settings, and methodologies to perform effective periodontal photonic treatments and to
extrapolate some recommendations for clinical use. Should these recommendations find a consensus
among periodontologists and be adopted in future clinical studies, they will hopefully contribute to
dissipate the present confusion and uncertainty on this complex matter.
Keywords: periodontitis; dental laser; light-emitting diode; photoablative therapy; photodynamic
therapy; photo-biomodulation
1. Introduction
In a recent review dedicated to the most important advancements in periodontology over the past
quarter-century, Professor C.M. Cobb underlines the fact that, in this period, the accumulated reports
and clinical studies have failed to provide enough body of evidence to prove or disprove the actual
utility of laser therapy in periodontitis [1]. As yet, the meta-analyses conducted on more than one
hundred human clinical studies have not collected sufficient statistical evidence to suggest that
integration of a laser, either as a monotherapy or as an adjunct to surgical and nonsurgical therapy in
a periodontal treatment protocol will provide clinical outcomes superior to those achieved by traditional
therapy based on scaling and root planing (SRP) [2]. It seems paradoxical that the many scientific data
made available over time have not delineated a clear trend, not to mention broadly shared indications
and protocols for laser therapy. In fact, the use of light for curative purposes, or ‘photonic therapy’,
is intrinsically complex because of many physical, biological, anatomical, and technical variables
which can have a profound influence on the final effect. The many diverse photonic treatments,
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exploiting different light-emitting devices (laser and LED), wavelengths, beam power, and irradiation
modes, as well as the heterogeneous treatment protocols, exact biological rationale, follow-up times,
disease grading, and assessment methods all contribute to make the literature on the clinical effects of
photonic therapy in periodontal treatment controversial and difficult, if not impossible, to interpret [1].
Unfortunately, this leads dentists to underestimate the actual potential of this therapeutic approach in
periodontal diseases.
This article is not intended as a replica of the numerous excellent reviews and meta-analyses
written by eminent periodontologists, to which we refer the reader who wishes to study this matter in
greater depth [1,3–10]. Having been involved for several years in the study of photonic therapies in
periodontics, we have felt the need for standardized, specific guidelines for the correct delivery of such
therapies, particularly as an adjunct to conventional SRP, to provide non-invasive, patient-friendly,
effective periodontal care [6]. In this critical appraisal of the literature available in the PubMed database
(published in English), both reviews and primary clinical research, we have briefly summarized the main
photonic therapies and instruments used in Periodontology, highlighting their main characteristics
and limitations. Then, we have tried to identify and discuss the key methodological issues, emerged from
our and others’ studies, which can have an impact on the outcome of the photonic therapies. Our goal
is to elicit the attention of periontologists towards these points when planning a periodontal photonic
treatment. Should these points become a shared base, they could be adopted as recommendations for
future clinical studies, hopefully contributing to the disambiguation of the actual therapeutic value of
the photonic approach.
2. Photonic Therapy and Devices
The premise for and basis of photonic therapy is that the light is used to improve the patients’ state
of disease. For this reason, the light itself is currently viewed as the main subject while the devices used
to administer it have been passing into the background. In fact, understanding of the physical properties
and parameters of light is an obligatory step when setting up a photonic treatment and maximization
of its therapeutic effects is chiefly if not exclusively related to the correct setting of key parameters such
as : (i) Wavelength (λ), (ii) pulsed or continuous mode, (iii) intensity and dosage, (iv) fluence, (v) time,
(vi) optical properties of the tissue itself, (vii) scattering of light within tissue, and (viii) absorption of
the light by chromophores (hemoglobin, myoglobin, and melanin) [11]. Therefore, these parameters
should always be taken into account and adjusted to the subjects, target tissues and therapeutic
objectives. That said, the devices currently used for photonic therapy in periodontics are basically
lasers and LED illuminators.
Lasers have been the first instruments developed for photonic therapy because of their
unique properties of emitting a collimated, coherent light beam with monochromatic synchronous
wavelength [12,13]. These characteristics allow medical lasers to be particularly versatile, since they
can operate with specific wavelengths, high-energy or low-energy light beam, continuous, or pulsed
wave mode, thus allowing a fine tuning of irradiation on the target tissues [3,13]. In particular,
based on the energy level of irradiation, laser-based therapy can be distinguished between
photosurgical/photoablative and low-energy therapy, also called low-level laser therapy (LLLT),
which encompasses the phototherapic, photodynamic and photobiomodulating modalities.
In recent years, for low-energy photonic therapy, non-coherent light sources such as light-emitting
diodes (LED) have become increasingly common. The recent advancements in LED technology have
consolidated their obvious advantages over lasers: negligible safety concerns, suitability for wearable
devices and home use, possibility to irradiate large tissue areas at once and—last but not least—much
lower costs of LED-based irradiation instruments [14].
3. Photoablative Therapy
This approach, requiring the use of lasers, exploits a high energy transfer to the target tissue
to achieve its selective destruction, thus substituting the surgical scalpel: in addition, it also offers
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excellent hemostatic and bactericidal effects, leading to less inflammatory reaction and faster healing.
Although high-energy lasers can also be used for soft and hard tissue photo-surgery, in the field
of periodontology non-surgical therapeutic approaches are most common: Therefore, they will be
the focus of this article. Energy absorption by the target varies depending on wavelength [15]:
Thus, the lasers emitting in the far or intermediate infra-red spectrum, such as CO2 (λ = 10,600 nm)
and Erbium family lasers, including Erbium-doped Yttrium-Aluminium garnet (Er:YAG; λ = 2940 nm)
and Erbium-Chromium Yttrium Scandium Gallium garnet (Er:YSGG; λ = 2780 nm), are absorbed
primarily by H2O (and secondarily by apatite) and operate chiefly through vaporization, whereas
those emitting in the near infra-red spectrum, such as Neodymium-doped YAG (Nd:YAG; λ = 1064 nm)
or diode (λ = 655–980 nm) lasers, are absorbed by tissue macromolecules and pigments and operate
chiefly by coagulation/carbonization [3]. The different wavelengths also influence other parameters,
such as light delivery by direct beam or optical fiber, penetration depth, light scattering, and related
undesired thermal side effects, which render each laser type best suited for different, specific applications
in the field of periodontology. Because of the narrow gap between therapeutic and unwanted side effects,
the use of photoablative devices should be restricted to expert practitioners upon extensive training.
Erbium family lasers (λ = 2940–2790 nm). These lasers, whose photonic energy can be delivered
either in contact or in non-contact mode, are mainly used to remove calculus, necrotic cementum,
bacterial biofilm and endotoxins from the root surface and for alveolar bone surgery [16]. Due to
its high absorption in water, Er:YAG laser induces sudden photo-thermal evaporation of the water
contained into the mineralized tissues, leading to micro-explosions and ablation of a thin layer of
the targeted tissues [17]. High water absorption is inversely proportional to reflection, scattering,
and transmission of the infra-red radiation, which accounts for minimal energy spreading and thermal
side effects in the surrounding tissues, not exceeding a range of 50 µm [18]. Pre-clinical and clinical
studies have shown that Er:YAG laser can remove calculus with similar efficacy as SRP [19–23],
albeit at the expense of an increased loss of cementum and dentin [24]. To limit undesired removal of
root tissues, a combination of pulsed emission at frequency >10 Hz and low energy (40–100 mJ/pulse,
energy density 10–20 J/cm2) is recommended [3,25]. Several studies emphasize the relationship
between increasing power and energy density and increased removal of root surface tissue [24,26,27].
Water spray cooling is also recommended to further reduce undesired thermal effects, albeit with
the caveat that adequate water cooling in deeper periodontal pockets is probably negligible. In turn,
water can enhance the laser effects as it results in a micro-structured root surface [17,20,28,29] which may
favor periodontium–root re-attachment and improvement of clinical at tachment level (CAL) in the long
term [22,30,31]. Of note, the clinical studies with sufficiently long follow-up periods have shown
that Er:YAG laser, either in place of or in adjunct to manual or ultrasonic SRP, has similar efficacy
to the conventional mechanical treatment in terms of standard periodontal markers probing pocket
depth, bleeding on probing and CAL [30,32]. Conceivably, the long-term clinical efficacy of the Er:YAG
laser is also related to its capability to eliminate periodontopathic bacteria and their endotoxins [33,34]:
This property can positively influence the host–parasite balance and reduce destructive periodontal
inflammation. In contrast to root photoablation, supra-gingival laser scaling on coronal enamel is
contra-indicated, since complete calculus removal without affecting the underlying enamel is nearly
impossible [3].
To enhance its precision, Er:YAG laser was coupled with a 655-nm diode laser to detect calculus
by induced fluorescence, enabling effective removal of subgingival calculus while preserving integrity
of the root surface [35]. This experiment demonstrates the usefulness of a diagnostic feedback system,
a smart innovation that could be implemented in the next generation of photoablative lasers.
On the other hand, Er:YAG laser is not the best choice for soft tissue surgery: despite the fact that
abundance of tissue water allows easy and effective cutting of the gingiva and oral mucosa without
substantial thermal damage, this laser, due to its micro-explosive mode of action, causes marked
bleeding as well as splattering of cooling water and blood [3,36]. Being absorbed chiefly by water,
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its effects are not substantially influenced by tissue pigments such as hemoglobin and melanin, requiring
no substantial adjustments of irradiation parameters related to local hyperemia or pigmentation [37].
Based on a selection of recent publications, in which the authors have reported the parameters
and settings used to deliver an effective treatment in sufficient detail to allow anyone to repeat
the treatment with any Er:YAG laser device [16,38–41], the suggested settings of photoablative Er:YAG
laser for dental root debridement are summarized in Table 1.
Table 1. Suggested parameters for photoablative Er:YAG laser.
Source (reference No.) [16] [38] [39] [40] [41] Overall suggestions
Laser emission settings
λ (nm) 2940 2940 2490 2490 2940 2490
Wave emission mode
(continuous/pulsed) pulsed pulsed pulsed pulsed pulsed pulsed
Pulse energy (mJ) 160 100 (71) * 160(114–136) * 160 40 40-160
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Nd:YAG laser (λ = 1064 nm), generally operating in pulsed wave mode, is poorly absorbed in water and 
chiefly absorbed by pigments, mainly melanin: this allows laser beam energy to penetrate deeply into tissues 
and cause photothermal coagulation. This property renders Nd:YAG laser particularly suited for soft tissue 
surgery, being able to achieve a sharp incision, 0.3–0.8 mm deep, with little or no pain, immediate hemostasis, 
and  excellent  post‐surgical  healing  [44].  These  properties  have  also  been  exploited  to  achieve  selective 
photoablation of the gingival epithelium, which can be more rapidly, safely, and effectively removed than 
with any  conventional  surgical approach, with no bleeding, no need  for anesthesia and no  injury of  the 
underlying mucosal lamina propria [45]. On the other hand, the same energy transfer features pose major 
limitations to its use on dental hard tissues: although Nd:YAG has been shown to be capable of removing 
subgingival calculus, even if less effectively than mechanical SRP, and of promoting satisfactory periodontal 
decontamination and healing [46], the effective irradiation power is very close to that inducing severe thermal 
damage to dental root and pulp tissues, narrowing the therapeutic window to output power settings between 
1.5  to 3 W  (60–150 mJ/pulse at 10–20 Hz)  [3]. This  issue  likely accounts  for  the controversial reports and 
overall  limited  clinical  evidence  regarding  the  actual  usefulness  of  photoablative  Nd:YAG  laser  in 
periodontology.  Its use  is discouraged  as  a monotherapy  for  root  curettage  and  should be  restricted  to 
removal of the infected epithelium and granulation tissue in adjunct to SRP [3,9,45]. It is noteworthy that 
Nd:YAG laser has been the object of accurate clinical studies whose results have allowed to draw a detailed 
periodont l protocol  termed  ‘l ser‐assisted new attachment procedure’  (LANAP)  [47]. Standardizatio  of 
this  procedure  has  all wed  to  consistently  achieve  satisfactory  gingival  re‐attachment  and  periodontal 
healing [48]. 
Based on a  selection of  recent publications  in which  the authors have  reported  the parameters and 
settings used to deliver an effective treatment in sufficient detail to allow anyone to repeat the treatment with 
any Nd:YAG laser device [49–52], the suggested settings of photoablative Nd:YAG laser for soft and hard 
tissue treatment are summarized in Table 2. 
Table 2. Suggested parameters for photoablative Nd:YAG laser. 
Source (reference No.) [49] [50] [51] [52] Overall suggestions 
Laser emission settings 
λ (nm) 1064 1064 1064 1064 1064 
Wave emission mode  
(continuous/pulsed) pulsed pulsed pulsed pulsed pulsed 
Pulse energy (mJ) 100 180–200 80 100 80–200 
 Frequency (Hz) 20 20 50 10 50–20 
Pulse width (ms)  0.1–0.15 0.55–0.65 0.35  ND 
Peak power (W)   240  ND 
Average power (W) 2 3.6–4.0 5 1  5 
Applicator characteristics 
Tip type,  
diameter (mm) / area (mm2) optic fiber 
optic fiber  
0.36 / 0.10 
optic fiber 
0.6 / 0.28 
optic fiber 
0.2 / 0.003  
optic fiber  
0.3–0.6 
Beam divergence (degree)     ND 
Fluence at tip level (J/cm2)  176.83–196.48 28.29 318.31  200 
Beam average power 
density (W/cm2)  3536–3930 1430 3183 1400–4000 
Beam peak power density 
(W/cm2)  
 85.800  ND 
Laser application details 
Application mode  
(contact/non-contact) Contact Contact Contact Contact Contact 
Frequency (Hz) 10 10 10 10 40 40-10
Pulse width (ms) 0.25–0.5 0.1 ND
Peak o er ( ) 400–200(284–142) * 400 ≤400
Average power (W) 1.6 1.0 (0.71) * 1,6(1.14–1.36) * 1.6 1.6 ≤1.6
Applicator characteristics
Tip shape and size (mm)
chise
l0.5 × 1.65
0.5 × 1.1
chisel
1.1 × 0.5
chisel
0.5 × 1.65
0.5 × 1.1
chisel round 0.4 round 0.5chisel 0.5–1.1
Beam divergence (degree) ND
Fluence at tip level (J/cm2)
19.39
29.91
18.18
(12.91) * 18.8–14.5 31.83 ≤50
Laser application details
Application mode
(contact/non-contact) contact contact contact contact contact contact
Distance (mm) 0
Laser spot size (mm2) ND
Beam inclination (degrees) 15–20 30 15–20 15–20 15–20
Power density (W/cm2) ND
Energy density (J/cm2) 12.9 ND
Treatment surface (cm2) ND
Tip movement speed (mm/s) ND
Total energy density (J/cm2) ND
Treatment details
Treatment time (s)
single (S)/multiple (M) dental
roots
600 S
960 M 180–240
till smooth
surface
dependent on whole
surface
No. of treatment 1 1 1 1 1 1
Cooling system water water water + air water + air28 mL/min
water + air
≥28 mL/min
Blue lines report the laser devices settings, yellow lines report data relevant to target irradiation, green lines report
data relevant to the applied therapeutic procedure. Among the reported studies, there is a considerable variability
in the mode, power, dose, number and frequency of treatment sessions, and not all the irradiation parameters
and modes are consistently reported (blank boxes, not reported). Based on the results obtained in these studies,
the right column extrapolates the suggested settings and parameters. Some of these are lacking (ND, not determined):
the underlined ones are crucial and need to be specifically investigated by further studies. The values indicated by
the square bracket are inversely related. * The values in parentheses correspond to those measured at the handpiece
tip, while the preceding values are those indicated at the instrument’s display.
CO2 laser (λ = 10,600 nm) is readily absorbed by water and is very effective for soft tissue surgery,
having excellent hemostatic and bactericidal effects [3]. At variance with Er:YAG laser, however,
it is also absorbed by the inorganic components of dental hard tissues and bone causing immediate
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over-heating and severe thermal damage [42], which deeply alters the root surface and hinders
successive periodontal re-attachment [43]. Because of this feature, CO2 laser is contra-indicated for
mineralized tissue photoablation. The only suitable mode of use in periodontics is in pulsed-wave,
defocused beam mode to eliminate bacteria and their endotoxins in adjunct to conventional SRP [3].
The use of photoablative CO2 laser for soft tissue periodontal treatment is limited and the existing
literature does not suffice to suggest specific treatment recommendations.
Nd:YAG laser (λ= 1064 nm), generally operating in pulsed wave mode, is poorly absorbed in water
and chiefly absorbed by pigments, mainly melanin: this allows laser beam energy to penetrate deeply
into tissues and cause photothermal coagulation. This property renders Nd:YAG laser particularly
suited for soft tissue surgery, being able to achieve a sharp incision, 0.3–0.8 mm deep, with little or no
pain, immediate hemostasis, and excellent post-surgical healing [44]. These properties have also been
exploited to achieve selective photoablation of the gingival epithelium, which can be more rapidly,
safely, and effectively removed than with any conventional surgical approach, with no bleeding, no need
for anesthesia and no injury of the underlying mucosal lamina propria [45]. On the other hand, the same
energy transfer features pose major limitations to its use on dental hard tissues: although Nd:YAG has
been shown to be capable of removing subgingival calculus, even if less effectively than mechanical SRP,
and of promoting satisfactory periodontal decontamination and healing [46], the effective irradiation
power is very close to that inducing severe thermal damage to dental root and pulp tissues, narrowing
the therapeutic window to output power settings between 1.5 to 3 W (60–150 mJ/pulse at 10–20 Hz) [3].
This issue likely accounts for the controversial reports and overall limited clinical evidence regarding
the actual usefulness of photoablative Nd:YAG laser in periodontology. Its use is discouraged
as a monotherapy for root curettage and should be restricted to removal of the infected epithelium
and granulation tissue in adjunct to SRP [3,9,45]. It is noteworthy that Nd:YAG laser has been the object
of accurate clinical studies whose results have allowed to draw a detailed periodontal protocol termed
‘laser-assisted new at tachment procedure’ (LANAP) [47]. Standardization of this procedure has
allowed to consistently achieve satisfactory gingival re-attachment and periodontal healing [48].
Based on a selection of recent publications in which the authors have reported the parameters
and settings used to deliver an effective treatment in sufficient detail to allow anyone to repeat
the treatment with any Nd:YAG laser device [49–52], the suggested settings of photoablative Nd:YAG
laser for soft and hard tissue treatment are summarized in Table 2.
Diode lasers (λ = 630–980 nm), also emitting in the IR spectrum, are particularly versatile since
they can operate in continuous or pulsed wave mode and, being delivered through optic fibers,
in contact or non-contact mode. Laser diodes are usually capable of operating at high pulse rate
(up to tens of kHz) and small pulse width (up to 1 µs). Recently, several semiconductor manufacturers
have proposed new diodes functioning at >10 MHz and pulse width < 10 nsec. Their IR radiation is
poorly absorbed in water but highly absorbed by pigments, particularly hemoglobin and melanin,
resulting in good penetration into tissues, albeit lesser than Nd:YAG laser [53]. On the other hand,
when used in contact mode, diode lasers show the phenomenon called ‘hot tip’: this consists of
carbonization of organic debris at the tip of the optic fiber generating a dark capping which, under
irradiation, at tains high temperature and works similarly to electro-cauterization [53]. Peculiarly,
the operating wavelengths of diode lasers do not substantially interact with mineralized tissues,
allowing safe usage of these devices for periodontal soft tissue surgery and sulcular debridement,
being particularly suited to achieve tissue ablation, hemostasis and sterilization even in close proximity
to dental roots [4,9,36]. Similarly to Nd:YAG, diode lasers (λ = 810 nm) have been successfully used
for selective photoablation of the gingival epithelium, with excellent hemostasis, no perceived pain
and minimal injury of the underlying mucosal lamina propria [36,45,54,55]. Since the rate of heat
generation by diode lasers is higher than Nd:YAG [56], operation under airflow cooling is required to
prevent unwanted thermal injury, especially when this is used in contact mode [36]. Conversely, most
studies agree that diode lasers are not suited for calculus removal and dental hard tissue treatment
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because they are ineffective at low irradiation energy while they cause undesirable alterations of
the root surface at high irradiation energy [23].
Table 2. Suggested parameters for photoablative Nd:YAG laser.
Source (reference No.) [49] [50] [51] [52] Overall suggestions
Laser emission settings
λ (nm) 1064 1064 1064 1064 1064
Wave emission mode
(continuous/pulsed) pulsed pulsed pulsed pulsed pulsed
Pulse energy (mJ) 100 180–200 80 100 80–200
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periodontal protocol  termed  ‘laser‐assisted new attachment procedure’  (LANAP)  [47]. Standardization of 
this  procedure  has  allowed  to  consistently  achieve  satisfactory  gingival  re‐attachment  and  periodontal 
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settings used to deliver an effective treatment in sufficient detail to allow anyone to repeat the treatment with 
any Nd:YAG laser device [49–52], the suggested settings of photoablative Nd:YAG laser for soft and hard 
tissue treatment are summarized in Table 2. 
Table 2. Suggested parameters for photoablative Nd:YAG laser. 
Source (reference No.) [49] [50] [51] [52] Overall suggestions 
Laser emission settings 
λ (nm) 1064 1064 1064 1064 1064 
Wave emission mode  
(continuous/pulsed) pulsed pulsed pulsed pulsed pulsed 
Pulse energy (mJ) 100 180–200 80 100 80–200 
 Frequency (Hz) 20 20 50 10 50–20 
Pulse width (ms)  0.1–0.15 0.55–0.65 0.35  ND 
Peak power (W)   240  ND 
Average power (W) 2 3.6–4.0 5 1  5 
Applicator characteristics 
Tip type,  
diameter (mm) / area (mm2) optic fiber 
optic fiber  
0.36 / 0.10 
optic fiber 
0.6 / 0.28 
optic fiber 
0.2 / 0.003  
optic fiber  
0.3–0.6 
Beam divergence (degree)     ND 
Fluence at tip level (J/cm2)  176.83–196.48 28.29 318.31  200 
Beam average power 
density (W/cm2)  3536–3930 1430 3183 1400–4000 
Beam peak power density 
(W/cm2)  
 85.800  ND 
Laser application details 
Application mode  
(contact/non-contact) Contact Contact Contact Contact Contact 
Frequency (Hz) 20 20 50 10 50–20
Pulse width (ms) 0.1–0.150.55–0.65 0.35
ND
Peak power (W) 240
Average power (W) 2 3.6–4.0 5 1 ≤5
Applicator characteristics
Tip type,
diameter (mm)/area (mm2)
optic
fiber
optic fiber
0.36/0.10
optic fiber
0.6/0.28
optic fiber
0.2/0.003
optic fiber
0.3–0.6
Beam divergence (degree) ND
Fluence at tip level (J/cm2) 176.83–196.48 28.29 318.31 ≤200
Beam average power density (W/cm2) 3536–3930 1430 3183 1400–4000
Beam peak power density (W/cm2) 85.800 ND
Laser application details
Application mode
(contact/non-contact) Contact Contact Contact Contact Contact
Distance (mm) 0 0 0 0 0
Laser spot size (mm2) ND
Beam inclination (degree) ND
Power density (W/cm2) 1430 ≤1400
Energy density (J/cm2) 12–17 ND
Energy (J) 240–480per tooth 240–480
Treatment surface (cm2) ND
Tip movement speed (m/s)
slowly
moved,
circular
moved
continuously
slowly
moved
sweeping
ND
Total energy density (J/m2) ND
Treatment details
Treatment time (s) 60–120per tooth 120
dependent on whole
surface
No. of treatment 1 1 1 1 1
Cooling system water + air air
Blue lines report the laser devices settings, yellow lines report data relevant to target irradiation, green lines report
data relevant to the applied therapeutic procedure. Among the reported studies, there is a considerable variability
in the mode, power, dose, number and frequency of treatment sessions, and not all the irradiation parameters
and modes are consistently reported (blank boxes, not reported). Based on the results obtained in these studies,
the right column extrapolates the suggested settings and parameters. Some of these are lacking (ND, not determined):
the underlined ones are crucial and need to be specifically investigated by further studies. The values indicated by
the square bracket are inversely related.
Based on a selection of recent publications in which the authors have reported the parameters
and settings used to deliver an effective treatment in sufficient detail to allow anyone to repeat
the treatment with any diode laser device [36,55,57–62], the suggested settings of photoablative diode
laser for soft tissue treatment are summarized in Table 3.
Int. J. Mol. Sci. 2019, 20, 4741 7 of 25
Table 3. Suggested parameters for photoablative diode laser.
Source (reference No.) [57] [58] [59] [60] [61] [62] [36,54,55] Overallsuggestions
Laser emission settings
λ (nm) 810 980 810 980 940 810 810 810–980
Wave emission mode
(continuous/pulsed) continuous pulsed continuous pulsed pulsed pulsed continuous Both*
Pulse width (ms) 10 25 20 10–25
Frequency (Hz) 30 13 25 50 10–30
Peak power (W) 1.5 2 1.5 2.5
Beam power (W)
(average power if pulsed) 1 1.5 1.5 0.66 1.5 1 1 1
Applicator characteristics
Tip type/diameter (mm)
optic
fiber
0.6/0.28
optic
fiber
0.4/
optic
fiber
0.4/
optic
fiber
0.3
optic
fiber
0.3
optic
fiber
0.3
optic fiber
polyimide-coated
silica 0.6
0.4–0.6
Beam diameter (mm) 0.28 ND
Beam divergence (degree) 16 ND
Laser application details
Application mode
(contact/non-contact)
‘hot tip’ inizialization (Y/N)
Contact
Y
Contact
Y
Contact
N
Contact
Y
Contact
Y
Contact
Y
Contact
Y
Contact
Y
Laser spot size (mm2) 0.28 ND
Beam inclination (degree) 20 15–20 15–20
Power density (W/cm2) 1193.7 353.4 1193.7–353.4
Total energy density
(fluence) (J/cm2) 15 66.7 66.7
Laser tip movement,
- time per area (s/cm2)
- linear speed (mm/s)
vertical
and horizontal
lines
vertical
nd horizontal
lines
vertical
nd horizontal
lines
vertical
nd horizontal
lines
vertical
and horizontal
lines 20
s/cm2
vertical
nd horizontal
lines
2.5 mm/s
vertical
and horizontal
lines
2.5 mm/s
vertical
and horizontal
lines 2.5 mm/s
Treatment details
Treatment time/tooth (s)
adjusted
depending
on
the pocket’s
surface
area
60 20 20 20 20
adjusted
depending on
the pocket’s
surface area
adjusted
depending on
the pocket’s
surface area
No./Frequency of
treatments 1 1 2 3 1 1 1 1–3
Cooling system no no no no no no airflow airflow
External power meter check no no yes no no no yes yes
Blue lines report the laser devices settings, yellow lines report data relevant to target irradiation, green lines report
data relevant to the applied therapeutic procedure. Among the reported studies, there is a considerable variability
in the mode, power, dose, number and frequency of treatment sessions, and not all the irradiation parameters
and modes are consistently reported (blank boxes, not reported). Based on the results obtained in these studies,
the right column extrapolates the suggested settings and parameters. Some of these are lacking (ND, not determined):
the underlined ones are crucial and need to be specifically investigated by further studies. * Pulsed wave mode is
preferable in case of gingival pigmentation.
Other lasers, such as alexandrite crystal laser and excimer laser emitting in the UV spectrum
(λ < 400 nm), have been investigated for possible use in periodontics because of their ability to be
absorbed by pigments in dental calculus, which could be selectively ablated [63,64], but the evidence
collected so far is too preliminary to draw any conclusion on their efficacy, while the use of high-energy
UV radiation has raised safety concerns [3].
At present, no clinical protocols and settings are available for these lasers.
4. Low-Energy Photonic Therapy
In a modern meaning, the term ‘low level laser therapy (LLLT)’ to designate the curative effects of
low power or defocused laser light should be replaced with ‘low-energy photonic therapy’. In fact,
whether the light source is a laser, LED or other device, the biological and therapeutic effects depend on
the specific wavelengths and irradiation modalities used (chiefly intensity, fluence rate, and treatment
duration). Rather, based on the achieved effects, it makes sense to distinguish low-energy photonic
therapy into (i) phototherapy, (ii) photodynamic therapy (PDT), and (iii) photobiomodulation therapy
(PBMT). In the field of periodontology, low-energy photonic therapies are never stand-alone protocols
but are rather intended as adjunctive treatments to conventional and laser-aided primary therapies
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Phototherapy indicates a direct biological action of specific wavelengths. In periodontics, this is
chiefly exploited to achieve antimicrobial effects, based on the occurrence of target pigments in sensitive
bacterial species, including several periodontal pathogens. The IR wavelengths of Nd:YAG and diode
lasers, even when used in photoablative mode, can scatter in the surrounding tissues where they are
lethally absorbed by black-pigmented gram negative anaerobes, including Bacteroides, T. denticola,
and P. gingivalis: this phenomenon may contribute to the reported improvement of clinical outcome in
patients receiving adjunctive laser treatments compared with those who only received conventional
periodontal therapy (e.g., SRP) [65,66]. This finding, however, has been questioned by other studies
showing that subgingival bacteria usually do not produce dark pigments and those doing so are
a minority of the total bacterial populations in periodontitis patients [67,68]. Given the hundreds of
bacterial species in the human periodontium, it is unfeasible to achieve a complete, enduring pocket
sterilization by means of IR lasers [1].
More encouraging perspectives are offered by phototherapy in the violet-blue spectrum
(λ 405–520 nm), which has shown excellent bactericidal effects against both Gram-positive
and Gram-negative pathogens [69,70]. The mechanisms of these effects have been only partly elucidated:
Among the possible modes of action, violet-blue light has been shown to excite bacterial porphyrins to
endogenously produce bactericidal reactive oxygen species (ROS) [71]. Of note, in vitro studies have
demonstrated that numerous periodontal pathogens, both in pure culture or in dental plaque, underwent
significant growth reduction and death upon irradiation with blue light (LED, λ 455 nm) [72]. Interestingly,
blue light (LED, λ 405 nm) at bactericidal dose has no effect on mammalian cells, which are protected from
the ROS-dependent oxidative stress by potent endogenous anti-oxidant mechanisms [73]. This unique
feature accounts for substantial efficacy and safety of blue light for oral disinfection. An additive
beneficial effect of blue light (LED, λ 405 nm) consists in inactivation of lipopolysaccharide (LPS) [74],
a Gram-negative endotoxin which plays a major role in maintenance of inflammation and periodontal
tissue destruction in chronic periodontitis [75]. Obviously, as any antiseptic treatment in periodontology,
blue light phototherapy needs to be repeated until a satisfactory clinical effect is achieved.
Blue light also has additional photodiagnostic properties: It was found that dental plaque often
exhibits red fluorescence when irradiated with blue light at λ 405 nm. This phenomenon is related to
endogenous porphyrins produced by certain periodontal microorganisms emitting in the red spectral
region when excited with light ranging from λ 400 to 420 nm [76]. Thus, irradiation with a blue
light LED of the dental and periodontal tissues can allow an accurate detection of contaminated sites,
useful to set up and monitor the antiseptic treatments (Figure 1).
The use of phototherapy with λ 405 nm LED for supportive periodontal treatment is limited yet.
Based on the positive results of our previous study [55], an effective setting can be as follows: beam
power, 1 W; power density, 1.05 W/cm2; total energy density (fluence), 63 J/cm2; non-contact irradiation
mode (10 mm from the tissue; spot area at the target, 95 mm2).
Photodynamic therapy (PDT) is based on the photochemical properties of certain organic
compounds such as cyclic tetrapyrroles, boron dipyrromethene (BODIPY), fullerenes and phenotiazinic
dyes, the latter including toluidine blue O, methylene blue and its derivatives [76]. These compounds,
generally termed ‘photosensitizers’, are absorbed by bacteria in an inert form and are subsequently
photo-activated, i.e. excited by light at appropriate wavelength to their reactive triplet state [77,78].
There are two sequential photochemical pathways for the anti-bacterial effects of photosensitizer-based
PDT: The first step (type II photochemistry) involves generation of singlet oxygen, which readily reacts
to generate hydroxyl radicals (OH-) and, in cascade, ROS (type I photochemistry), which are considered
the main effectors of bacterial photodamage and cytotoxicity [77,79]. ROS are toxic to microorganisms
mainly through oxidative damage of plasma membranes and DNA [80]. Moreover, they have a short
half-life (about 0.04 µs) and limited radius effect (0.20 µm) which render them particularly effective
in the infected area, where the photosensitizers accumulate, with negligible undesired side effects
on the tissues nearby [81]. Of interest, some bacteria, especially Gram-negative ones, can induce
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(Er:YAG) laser on an extracted root. Arrows point at the treated area. (B) Red fluorescence of the contaminated 
root surface revealed upon irradiation with λ 405 nm blue light. (C) The same photodiagnostic approach is 
used to detect full‐mouth dental plaque. 
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Figure 1. (A,B): Photoablation of dental calculus and plaque by Erbium-doped Yttrium-Aluminium
garnet (Er:YAG) laser on an extracted root. Arrows point at the treated area. (B) Red fluorescence
of the contaminated root surface revealed upon irradiation with λ 405 nm blue light. (C) The same
photodiagnostic approach is used to detect full-mouth dental plaque.
In the last decade, numerous reports have shown that antimicrobial PDT can be a valuable
therapeutic approach in periodontal diseases, as it is able to eliminate bacteria [83], inactivate
their endotoxin LPS [84,85], reduce pro-inflammatory cytokines [86] and endothelial adhesion
molecules [45]. These biological effects synergize to reduce inflammation and periodontal tissue
destruction. Accordingly, multiple sessions of PDT adjunctive to surgical treatment for chronic
periodontitis have been shown to significantly improve the main periodontal clinical parameters in
short- and long-term follow-up [36,54,55,86,87].
A key issue in PDT is the choice of an appropriate excitation wavelength for the different
photosensitizers. Each molecule is characterized by a definite spectrum of excitation wavelengths
and the effective irradiation should fall within this spectrum, preferably close to the excitation peak.
Thus, to mention the most commonly used photosensitizers, methylene blue shows two close absorption
peaks at 635 and 670 nm, while toluidine blue shows a single peak at λ 628 nm [82,88]. The absorption
spectra of these phenotiazinic dyes, reported in Figure 2, clearly show that both compounds can be
photoactivated with light whose λ is encompassed between 550 and 700 nm. Therefore, the anti-bacterial
effects reported in previous studies in which methylene blue or toluidine blue were used in combination
with low-level IR diode lasers operating at λ 830 and 940 nm [89,90], which fall far beyond the absorption
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spectra of these photosensitizers, are not to be as cribed to PDT, but could rather be due to non-specific
thermal effects. In this context, the careful choice of appropriate photosensitizers and the relevant
irradiation wavelengths is mandatory when performing an effective PDT and would be desirable in
order to gather objective and reliable clinical data on the actual efficacy of PDT in periodontology.
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW  10 of 25 
In the last decade, numerous reports have shown that antimicrobial PDT can be a valuable therapeutic 
approach in periodontal diseases, as it is able to eliminate bacteria [83], inactivate their endotoxin LPS [84,85], 
reduce pro‐inflammatory cytokines  [86] and endothelial adhesion molecules  [45]. These biological effects 
synergize to reduce inflammation and periodontal tissue destruction. Accordingly, multiple sessions of PDT 
adjunctive to surgical treatment for chronic periodontitis have been shown to significantly improve the main 
periodontal clinical parameters in short‐ and long‐term follow‐up [36,54,55,86,87]. 
A  key  issue  in  PDT  is  the  choice  of  an  appropriate  excitation  wavelength  for  the  different 
photosensitizers. Each molecule is characterized by a definite spectrum of excitation wavelengths and the 
effective irradiation should fall within this spectrum, preferably close to the excitation peak. Thus, to mention 
the most commonly used photosensitizers, methylene blue shows two close absorption peaks at 635 and 670 
nm,  while  toluidine  blue  shows  a  single  peak  at  λ  628  nm  [82,88].  The  absorption  spectra  of  these 
phenotiazinic dyes, reported in Figure 2, clearly show that both compounds can be photoactivated with light 
whose λ is encompassed between 550 and 700 nm. Therefore, the anti‐bacterial effects reported in previous 
studies in which methylene blue or toluidine blue were used in combination with low‐level IR diode lasers 
operating at λ 830 and 940 nm [89,90], which fall far beyond the absorption spectra of these photosensitizers, 
are not to be ascribed t  PDT, but could rather be due to non‐specific thermal eff cts. In this context, the 
careful choice of appropriate photosensitizers and the relevant irr diation wavelengths is mandatory when 
performing a  effective PDT and would be desirable in order to gather objective and relia le clinical data on 
the actual efficacy of PDT in periodontology. 
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used as photosensitizers  in photodynamic  therapy  (PDT). Optimal photochemical  reactive oxygen  species 
(ROS)  generation  and  anti‐microbial  effects  are  achieved  with  light  wavelengths  coincident  with  the 
absorption peaks. 
Another key  issue  is  related  to  the  influence of  the  local  conditions of  the periodontal  tissues  to be 
treated. In fact, the efficacy of PDT is substantially reduced in the presence of bleeding and inflammation, 
since proteins in serum and exudate can compete in the tissue uptake of photosensitizers [91] and biological 
Figure 2. Abs rption spectra of toluidin blue O and methy ene blue, two phenotiazinic dyes most
commonly used as photosensitizers in photodynamic therapy (PDT). Optimal photochemical reactive
oxygen species (ROS) generation and anti-microbial effects are achieved with light wavelengths
coincident with the absorption peaks.
Another key issue is related to the influence of the local conditions of the periodontal tissues to be
treated. In fact, the efficacy of PDT is substantially reduced in the presence of bleeding and inflammation,
since proteins in serum and exudate can compete in the tissue uptake of photosensitizers [91]
and biological fluids can dilute them below the effective concentration. For the same reason, flushing
out the photosensitizer solution before irradiation should be avoided, as should the insertion of
the fiber tip in the periodontal pockets, as it can cause harm and bleeding. Rather, since red light
can easily penetrate the tissues, photoactivation should be performed by transgingival irradiation in
non-contact mode [92] (Figure 3). For the same reasons, in the presence of periodontal inflammation,
more numerous PDT sessions and longer treatment times can be needed to achieve satisfactory results.
Based on a selection of recent publications in which the authors have reported the parameters
and settings used to deliver an effective treatment in sufficient detail to allow anyone to repeat
the treatment with any laser or LED device [55,85,93–97], the suggested protocol of PDT with λ 635 nm
light source for supportive periodontal treatment is summarized in Table 4.
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in non‐contact mode using a λ 628 nm red light laser source and an adjustable‐focus handpiece. Lower panel: 
Irradiation is performed in contact mode using the same λ 628 nm red light laser source and a Ø 800 μm optic 
fiber inserted into the periodontal pockets: this procedure should be avoided because it can cause harm and 
bleeding and reduce the efficacy of PDT. 
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Table 4. Suggested parameters for photodynamic therapy (PDT). 
Source (reference 
No.) [93] [94] [95] [86] [96] [55] [97] 
Overall 
suggestions 
Laser emission settings 
λ (nm) 670 670 660 670 660 635 660 635/660 
Wave emission mode 
(continuous/pulsed) 
continuou
s 
continuou
s 
continuou
s 
continuou
s 
continuou
s 
continuou
s 
continuou
s continuous 
Applicator characteristics 
Tip type / diameter 
(mm) 
optic 
fiber 
optic 
fiber 
optic 
fiber 
0.6  
optic 
fiber  
0.6   
optic 
fiber 
0.6  
focalized 
zoom  
focalized 
zoom / 
optic fiber 
0.6 
Fluence at tip level 
(J/cm2) 10–20     129  14.9  129  21    21–129 
Power output (mW) 150    60  75  60  100  100  60–100 
Figure 3. Photodynamic therapy (PDT) with toluidine blue O. Upper panel: Irradiati n is corr ctly
perf rmed in non-contact mode using a λ 628 nm red light l ser source and an adjustable-focus
h ndpiece. L wer pa el: Irradiation is performed in contact mo e using the ame λ 628 nm red light
laser source and a Ø 800 µm optic fiber inserted into the perio ont l pockets: this procedure should be
avoided beca s it can cause harm and bleeding and reduce the efficacy of PDT.
Photobiomodulation therapy (PBMT), broadly used for medical and veterinary purposes, usually
exploits deeply penetrating IR wavelengths ranging between 600 and 950 nm to exert biostimulatory
effects in the irradiated tissues, mainly consisting in increased cell proliferation and microvascular
blood flow, which result in promotion of wound healing and bone regeneration and reduction
of local inflammation, fibrosis and pain [5,98–101]. The cellular mechanisms underlying PBMT
are many and only partially understood: Definitely, they are not dependent on mere thermal
effects but seem to involve photochemical activation of cellular pigments, such as cytochromes in
mitochondria, which enhance cell metabolism and availability of ATP and nitric oxide [5,102–104].
In the meantime, in vitro and in vivo studies have shown that irradiation with IR wavelengths used
for PBMT abates the production of pro-inflammatory cytokines stimulated by bacterial LPS or surgical
wounds [105,106], inhibits the transition of fibroblasts to pro-fibrotic myofibroblasts [107], promotes
growth and differentiation of mesenchymal stem cells and osteoblasts [108,109], and modulates the levels
of tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) in periodontal
tissues [110]. Consistently with the above notions, PBMT has been successfully used as co-adjuvant to
conventional periodontal treatment to reduce periodontal inflammation, accelerate wound healing
and gingival-root re-attachment, increase alveolar bone regeneration, and reduce post-operative pain [5].
However, the meta-analyses carried out on data from diverse reports have given inconclusive results,
mainly because of dis-homogeneous clinical protocols [111]. This issue has prompted a re-appraisal of
the right irradiation parameters for safe and effective PBMT [11]. As a final technical note, because of
their many advantages over low-level lasers, LED devices are becoming preferable for PBMT purposes.
Their simpler irradiation modalities should lead to more standardized clinical data and, hopefully,
a clearer scenario on the benefits of PBMT in periodontics.
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Table 4. Suggested parameters for photodynamic therapy (PDT).
Source (reference No.) [93] [94] [95] [86] [96] [55] [97] Overallsuggestions
Laser emission settings
λ (nm) 670 670 660 670 660 635 660 635/660
Wave emission mode
(continuous/pulsed) continuous continuous continuous continuous continuous continuous continuous continuous
Applicator characteristics
Tip type/diameter (mm) optic fiber optic fiber
optic
fiber
0.6
optic fiber
0.6
optic
fiber
0.6
focalized
zoom
focalized zoom/
optic fiber 0.6
Fluence at tip level (J/cm2) 10–20 129 14.9 129 21 21–129
Power output (mW) 150 60 75 60 100 100 60–100
Power density (W/cm2) 0.075 21.4 1.2 21.4 0.35 0.25 0.35–21.4
Laser application details
Application mode transgingival subgingival subgingival subgingival subgingival transgingival transgingival transgingival
Distance (mm) 7 0 0 0 30 30
spot diameter(mm)/area
(mm2) 90 6/28,3 ND
Beam inclination (degree) 90 90
Energy density (J/cm2) 2.4 21 75 21–75
Treatment surface (cm2) 128 0.4 ND
Photosensitizer
Metyhylene blue, MB
Toluidine blue, TB MB MB MB MB MB TB MB MB/TB
Solvent Periowave
TM
solution
HelboTM
solution
water Helbo
TM
solution
water water
Na
dodecyl-sulfate
in water
water
Rinsing time pre-irradiation
(min) 3 1 1 1 1 1-3
Concentration (mg/mL) 0.005 10 * 10 * 10 * 10 * 0.001 0.003 0.001–0.003without rinsing
Rinsing after application yes yes yes yes no no NO
Treatment details
Treatment time per tooth (s) 60 60 60 60 60 300 300
adjusted
depending on
the area of
each pocket
Treatment repetitions 1 4 1 4 1 7–10 1
4–10
adjusted
depending on
healing
markers **
External power meter check no no no no no yes no yes
Blue lines report the laser devices settings, yellow lines report data relevant to target irradiation, green lines
report data relevant to the applied therapeutic procedure. Among the reported studies, there is a considerable
variability in the mode, power, dose, number and frequency of treatment sessions, and not all the irradiation
parameters and modes are consistently reported (blank boxes, not reported). Based on the results obtained in these
studies, the right column extrapolates the suggested settings and parameters. Some of these are lacking (ND, not
determined). * Rinsing after application of the photosensitizer solution makes its actual concentration impossible
to determine: in this instance, a large dye excess (up to 10 mg/mL) can be justified. ** Objective as sessment of
residual microbial/inflammatory markers, e.g., by cytosmear of pocket exfoliative samples, is recommended to check
the effects of PDT and adjust its duration.
The protocols of PBMT with λ 635–810 nm laser or LED for supportive periodontal treatment
have been summarized in a recent review [111].
5. Multi-Photonic Therapy
In recent years, evidence is emerging that satisfactory clinical results in periodontology can be
obtained by a combination of multiple photonic treatments, in order to exploit the synergism between
their different biological effects. In 2011 we first developed and applied in a pilot trial on patients with
chronic periodontitis a multi-photonic approach adjunctive to SRP [36]. We started from the notion
that periodontal tissue destruction occurs because of persistent inflammation related to unresolved
infection by germs particularly adapted to the periodontal microenvironment, capable of penetrating
and persisting into epithelial cells of the periodontal pockets and outer gingiva, thereby escaping host
immunity and conventional anti-bacterial drugs [112,113] and predisposing the patients to re-infection
soon after SRP [114], disease relapses, and chronicization [115,116]. Given this problem, we reasoned
that a potential solution could consist in: (i) Laser photoablation of the infected epithelium, (ii) SRP
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for proper root cleansing, (iii) PDT with methylene blue in repeated sessions, to reinforce antisepsis
and shift the parasite-host balance towards periodontal healing. This protocol, which we termed ‘PAPD’
for ‘photoablative-photodynamic’, met our expectations because it was shown to significantly improve
the main periodontal clinical parameters in short- and long-term follow-up [36,54]. More recently,
we have adopted a modified protocol, named iPAPD for ‘improved PAPD’, in which epithelial
photoablation and SRP were followed by an intra-operative application of antiseptic phototherapy with
a λ 405 nm LED (5 min), before the repeated PDT sessions. This improved protocol also gave satisfactory,
statistically relevant clinical results in patients with severe periodontitis at 1-year follow-up [55].
The suggested iPAPD protocol for supportive periodontal treatment is summarized in Table 5.
Table 5. Suggested parameters for multi-photonic (iPAPD) periodontal therapy [55].
Photoablative
Diode Laser
Phototherapy
LED
PDT
Diode Laser
Laser emission settings
λ (nm) 810 405 635Toluidine blue (1 µg/mL)
Wave emission mode continuous continuous continuous
Beam power (W) 1 1 0.1
Laser application details
Handpiece
Diameter
(mm)
Optic fiber
0.6 Adjustable focus lens
Crystal lightpipe
10
Application mode
(contact/non-contact) contact non-contact non-contact
Distance (mm) 0 10 30
Light spot size (mm2) 0.28 95 28.3
Power density (W/cm2) 353.4 1.05 0.35
Total energy density (fluence) (J/cm2) 66.7 63 21
Tip movement speed (mm/s) 2.5
Treatment details
No. of treatment 1 1
4–10
adjusted depending on
healing markers *
Cooling system airflow
Blue lines report the laser devices settings, yellow lines report data relevant to target irradiation, green lines report
data relevant to the applied therapeutic procedure. * Objective as sessment of residual microbial contamination
and inflammation, as sumed as healing markers, was performed by cytosmear of pocket exfoliative samples,
as described [36].
6. Cellular and Molecular Effects of Photonic Treatments
The varying clinical effects of photonic treatments have their background in the diverse effects of
light at the cellular level. Albeit the molecular as pects of the cell and tissue response to light mainly
concern low-energy photonic irradiation, some of the collateral effects described upon photoablative
laser treatments can be as cribed to the same mechanisms, since light can scatter and diffuse to
the tissues nearby the area of impact of the laser beam. As briefly mentioned in the previous chapters,
visible (λ 400–760 nm) and infra-red (λ > 760 nm) light can have clinically exploitable beneficial effects,
which can be basically summary zed as : (i) Decreasing inflammation, (ii) analgesia, (iii) promoting
tissue repair [117–119]. If overall irradiation power is low, e.g., <500 mW, no substantial heating of
the tissues occurs and these effects can thus be considered light-specific, although they can substantially
vary depending on the used wavelengths and irradiation parameters [11,80]. To exert cellular effects,
absorption of photons of light radiation must occur. In fact, eukaryotic cells contain endogenous
chromophores which behave as initial photoacceptor molecules: thence, the absorbed energy of
photons is transferred to other molecules which play a role in cell function and metabolism [118].
The main chromophores and downstream molecular pathways activated by light can be resumed
as follows [117].
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(1) Cytochrome c oxidase (Cox): this is the final enzyme of the electron transport chain of
oxidative phosphorylation in mitochondria which catalyzes the electron transfer from cytochrome c to
molecular oxygen. Evidence has been offered that photons in the red/near infra-red λ can increase
the availability of electrons, acting as up-regulators of mitochondrial membrane potential and hence
ATP generation [120]. The exact molecular mechanism is yet unknown, although it could consist in
photodissociation from the Fe2+ and Cu2+ centers of Cox of the inhibitor and rate-limiting factor nitric
oxide (NO) [117]. Besides its obvious effects to support cell metabolism, increased ATP availability can
be related to the light-induced rise in intracellular cAMP, which in turn regulates multiple cellular
pathways involved in tissue repair and inflammation: For instance, cAMP inhibits TNF synthesis
and, thus, down-regulates the inflammatory process [117,118]. Reduction of inflammation is also
thought to be a main mechanism of the light-induced analgesia [117]. Increased mitochondrial activity
also results in enhanced generation of superoxide anion and related reactive oxygen species (ROS),
which in physiological concentrations can have stimulatory and signaling effects, promoting stem cell
differentiation, increase in Ca2+ flow, mitogen-activated protein kinase (MAPK) activation and cell
growth [119].
(2) Light-sensitive ion channels: these include for instance rhodopsin channels and transient
receptor potential (TRP) channels, whose activation causes influx of cations, such as Ca2+, and changes
in plasma membrane resting potential. Increased intracellular Ca2+ can modulate a number of
cell responses, including for instance activation of cell proliferation and migration and release of
tissue-trophic mediators from mast cells, which may concur to explain the tissue repair effects of
light irradiation.
(3) Metal ion-containing enzymes, such as Cu–Zn superoxide dismutase and heme-containing
peroxidase, involved in the regulation of intracellular redox potential and protection from
inflammation-induced oxidative stress.
Besides these primary targets, other cellular pathways have been shown to be activated upon light
irradiation, including expression of transcription factors, modulation of several cytokines and growth
factors, and up-regulation of heat shock proteins, although the exact mechanisms remain to be fully
elucidated [117]
It is known that if the incorrect parameters are applied, the photonic treatment is likely to be
ineffective. In fact, too low or too high doses—in terms of fluence (J/cm2), irradiance (mW/cm2),
irradiation time, or number of repetitions—can lead to no effects or even paradoxical inhibitory effects.
This biphasic response, or ‘hormesis’, follows the Arndt–Schulz law, stating that weak stimuli slightly
accelerate cellular activity, stronger stimuli raise it further until a peak is reached, whereas even
stronger stimuli suppress it until a negative response is achieved [117]. This peculiar phenomenon can
contribute to explain the above reported controversies about the clinical effects of photonic treatment
in periodontal disease therapy.
7. Traps and Tips of Photonic Therapy Protocols
A careful analysis of the data from the literature has highlighted the profound differences between
the several photonic therapies applied in periodontology, which in fact preclude to properly merge
these data and identify the most suitable clinical protocols [1]. Focusing on these differences, however,
enables us identify some key points which can be misleading if not properly taken into consideration
when planning a photonic therapy protocol. Some of them are sketched out below.
Replacement or adjunctive to SRP. In periodontitis patients, debridement of the diseased root
surface is usually performed by mechanical SRP using manual curettes or ultrasonic and air scalers.
Although there is a general consensus that complete removal of bacteria and their toxins from the root
surface and within the periodontal pockets cannot be achieved with conventional SRP, which provides
the strongest rationale to photonic therapies, the greatest controversies deal with the actual advantages
of replacing SRP with laser-aided debridement [1,3]. At present, only Er:YAG laser has shown
the potential for effective calculus removal and root debridement capable of giving satisfactory clinical
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results in the long term [30,32]. However, use of this laser on dental hard tissues should be restricted
to skilled operators, because it can easily result in increased loss of cementum and dentin and enamel
damage [3,24]. Moreover, because of its narrow therapeutic window, the actual energy output of
Er:YAG laser should be checked with a power meter at the fiber tip and adjusted before any treatment, in
order to achieve the desired results. Because of these limitations and cautions, photonic therapy should
be used in adjunct to conventional SRP rather than in its place for most periodontal applications [2].
Repeated irradiation, multiple sessions. Concerning low-energy photonic therapies, the previous
clinical studies have indicated that, in many instances, their efficacy is modest and the differences
with the control patients are often insignificant when they are delivered as a single treatment [85,86].
This is conceivable, taking into account that these photonic therapies are chiefly aimed at obtaining
anti-bacterial effects. Repeated treatment sessions can result in progressive reduction of periodontal
pathogens and their pro-inflammatory by-products, thus switching the host–parasite balance in favor of
the former, eventually promoting periodontal healing [1,5]. On the above grounds, two key questions
arise: how frequent and how many sessions. Frequency should be adjusted to prevent substantial
bacterial re-growth between the sessions. Ideally, daily sessions are preferable, but patients may be
annoyed by this: A possible solution would consist in portable photonic devices for self-administration
of PT or PDT to patients at home, under medical prescription and control. Duration of the treatment
should also be adjusted to each patient until satisfactory periodontal healing. In this context,
a substantial body of evidence has indicated that the severity and clinical course of periodontal disease
closely correlate with the local amounts and viability of the most aggressive periodontal bacteria,
such as spirochetes [36,121], as well as of polymorphonuclear leukocytes (PMN) and erythrocytes
which are reliable severity markers for periodontal inflammation and bleeding [36,54,55,122,123].
These parameters can be easily detected and quantified by cytological as say on smears of exfoliative
material from the diseased periodontium [36,122,124] and assumed as indicators of periodontal healing
to determine when PT or PDT can be safely discontinued [36,54,55]. Another feasible approach for
evaluating periodontal healing could be to monitor inflammation biomarkers in the gingival crevicular
fluid [125].
Photoablative laser irradiation: Speed vs. time. Safe and effective photoablation depends on
proper laser-tissue interaction. As discussed in the previous chapters, the physical characteristics of
the different lasers and their irradiation settings and modalities need to be chosen and optimized based
on the target tissue and the desired effects. A crucial point, often underestimated in many previous
studies, is the movement of the laser beam, usually borne by an optic fiber, on the targeted tissue
surface. Adopting speed as a main, objective parameter for target irradiation, photoablation results
from a succession of adjacent lines covering the whole surface under treatment (Figure 4).
In a typical photoablative treatment, the fiber tip is moved to cover the total surface to be treated by
drawing a sequence of contiguous stripes on the surface, as sketched in Figure 4, where v (considered as
a mean value) is the tip speed. Surface shape is unimportant, while the relevant parameters are: area
(S), number of stripes (N), and linear distance drawn by the tip (L).
In case of a rectangular surface and round beam cross-section, as shown in Figure 4, the following
formula can be applied:
N = h/hb (1)
where h is the height of the surface to treat and hb is the length of the laser beam cross-section
orthogonal to the movement line. Usually, in both contact and non-contact modes, the tip is not
held perpendicularly but inclined by an angle α, as represented in Figure 5: in the upper panel,
the rectangle represents the target tissue to be treated, the cone identifies the laser beam emitted from
the tip, while the red ellipse represents the laser beam cross-section at the target surface (a circle
section applicator is drawn, but similar considerations hold true for different types of applicators).
The lower panels show the clinical implementation of photoablation with a diode laser inclined towards
the gingival mucosa (left) and an Er:YAG laser inclined towards a dental root (right).
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Figure 4. Graphic representation of the treated root surface during a photoablative treatment.
Correct photoablation results from a succession of adjacent, non-overlapped lines covering the whole
surface area under treatment. Accordingly, the total time of the treatment Tt is given by the following
formula: Tt = N × Ts = N × 1S where S is the constant speed of the laser spot, N is the number of
lines, and Ts is the time required to treat a line.
The surface interested by the laser beam on the tissue is larger than the tip section, thus the fluence
at tissue will be lower than that at tip level. In particular, it can be calculated that beam cross-section
at target level (Starget) referring to the tip surface (Stip) and inclination angle (α):
Starget =
Stip
cos ∝ (2)
thus, fluence at target level (Ftarget) can be calculated as :
Ftarget =
Ep
Starget
=
Ep
Stip
cos ∝ = Ftip cos ∝ (3)
where Ep is the laser beam (pulse) energy.
It is to remember that cos ranges from 0 (tip parallel to the surface, = 90◦) to 1 (tip orthogonal o
the surface, = 0◦): in practice, with inclinations of 15◦–20◦, cos spans between 0.966–0.937, corresponding
to a 3.4%–6% reduction. At 30◦ inclination, the reduction is 86.7%, while at 45◦ it becomes 70.7%.
Speed is the key parameter to be considered: for most purposes, 2.5 ± 0.5 mm/s is adequate
to achieve effective photoablation while avoiding thermal damage of the target [126]. Operators
can practice the correct speed on millimeter paper or other substrates, e.g., dental wax sheets,
before implementing the treatments. Formulas to calculate the energy delivered to the target tissue
as a function of speed have also been reported previously [126]. Care must be taken to not overlap
the photoablation lines in order to avoid dual irradiation and possible tissue injury. Thus, the parameter
‘irradiation time’, often reported in previous studies to describe a photoablative procedure, becomes
meaningless as it varies from case to case depending on the surface areas to be treated: In view of
a better standardization of the photonic clinical protocols, its use should be discontinued.
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Figure 5. The diameter of the optic fiber, its angle (α) and distance from the target can deeply influence
the actual irradiation energy delivered to the tissue. If the fiber is angled at 45◦, the area of the irradiation
spot increases and the overall energy is scattered proportionally. The below panels are representative
of proper optic fiber angulati n during diode laser photoablatio of the gingival epithelium (left)
and Er:YAG photoablation of calculus from a dental root (right).
The tual irradiation energy at the target. Another crucial poi t, wh ch may have contrib ted
to confound the results of he previous clini al studies, relates to the irr diation energy delivered
to the targ t tissue, a key pa ameter for the efficacy of photonic therapies. In fact, especially for
photoablative lasers, the actual energy of the light beam at the tip of the handpiece may differ
substantially from the setting at the instrument’s display. Even when using new, high-quality optical
fibers, energy at the laser source is reduced by about 30% during transmission through the fiber, not to
mention the progressive us -rel t d abatement of energy transmittance due to deterioration of the fiber
material [38]. Because of these issues, before any photonic treatment, irradiation energy should be
checked at the output from the terminal handpiece by a calibrated optical power meter, a low-cost
instrument that should be present in the standard outfit of any photo-therapist, especially when
administering high-energy lasers treatments. In fact, the effectiveness of a laser device is mainly affected
by three key elements: (1) The laser source, where laser radiation is generated, (2) the delivery system,
which transmits laser radiation to the applicator, (3) the tip of the applicator, which supplies laser
radiation to the target. Faults, degradations or aging in any of them can result in improper treatments.
Usually, the system control of a modern device is able to check the laser source and compensate
some variations, usually the delivery system but not the tip. Verification of laser emission at t e tip
enables the operator to exclude malfunctions an assure the right instrument’s performance. Of note,
the current regulations concerning medical laser systems establish that laser emission is correct if
it is in the range of ±20% of the nominal set value. In normal use, this tolerance has little effect
on the treatment. However, in research and experimental field, where the results of treatments are
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evaluated to define the right protocols, such differences are significant. Two different devices, even from
the same manufacturer, with the same settings can yield completely different effects if their emissions
are at the two sides of the acceptance range (they actually differ by 40%) and no measure of the exact
emitted power is taken. In conclusion, it should be recommended that any new clinical studies report
the exact values of irradiation energy at the target expressed as J/cm2. Moreover, as underlined in
the previous chapter, speed of the fiber tip should be reported as well.
Other important parameters capable of deeply influencing the actual irradiation energy are
the diameter (Ø) of the optic fiber, its angle, and distance from the target surface. Assuming 0 as distance
(contact mode), a laser equipped with a Ø 300 µm fiber concentrates its energy on a spot roughly
corresponding to the fiber cross-section area, i.e. 70,650 µm2; if this fiber is replaced with a Ø 600 µm
fiber, the same energy is scattered on a 4-fold larger area, (282,600 µm2). Similarly, if the fiber is held
perpendicular to the target surface, the irradiation spot roughly corresponds to the fiber cross-section
area; if the fiber is angled at 45◦, the area of the irradiation spot increases and the overall energy is
scattered proportionally (Figure 5). Similar effect of light spot widening also occurs when the distance
between the fiber tip and the target surface increases, due to the refractive index of interposed air.
Continuous wave, pulsed wave. Diode lasers are increasing their share in the market of dental
lasers because of their favorable cost-performance ratio and versatility of use. In fact, these lasers can
be set to emit a continuous or pulsed light beam [3]. The continuous wave mode enables the operator
to easily estimate and control the energy delivered to the target tissue. The pulsed wave mode can be
obtained in two different ways, gated pulse and free-running pulse: A gated pulse consists in chopping
a continuous beam with a shutter operating at appropriate frequency, while a free-running pulse is
generated by pulsations occurring in the laser tube. The gated pulse keeps the same maximum power
of the continuous laser beam, while the free-running pulse allows to reach very high power peaks for
very short times, with the advantage of high energy delivery to the target while minimizing undesired
thermal side effects. There are no clear data helpful to define when continuous or pulsed wave modes
should be preferred [11]: For the different photonic treatments, the choice of either modality should be
checked towards the achieved results. In principle, in comparison with the continuous wave mode,
the pulsed mode allows to increase the peak photon intensity, or irradiance (W/cm2), while maintaining
the same overall dose, or fluence (J/cm2), and hence thermal effects.
8. Conclusions
Periodontologists are equally divided between supporters and skeptics about the usefulness
of photonic therapy, the discriminating factor being basically dependent on individual positive or
negative experience. Regretfully, as analyzed in the introduction, the excess of variables—not to
mention some overt mistakes—among the diverse therapeutic protocols of the previous clinical
studies have precluded to gain a sufficiently robust, statistically significant body of evidence in
support to the photonic approach [1,2]. However, a careful, critical appraisal of the data from
the literature has allowed us to identify several key points which, if they had been taken into proper
consideration, could have made the difference between correct and erroneous photonic procedures.
Two of these points appear particularly important: i) To be well aware of the makings and limitations
of the different photonic devices and techniques and to use them for the right purposes; ii) to report
in detail any methodological information needed to allow anyone to deliver a similar treatment
with any laser or LED device. In this line of thought, compliance with these points should be
adopted as benchmark to distinguish between correctly performed clinical studies to be included
in future meta-analyses and wrongly designed studies reporting misleading data which should
rather be excluded a priori. For instance, this criterion could be added to those in the AMSTAR
checklist for methodological as sessment of systematic reviews of clinical studies [127]. In prospective,
the reasoned recommendations proposed here for proper settings of the different photonic instruments
and procedures might desirably represent a starting base for further discussion to eventually arrive
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to a more standardized, consensual application of photonic periodontal therapy protocols in future
clinical studies.
A major limitation of our analysis is the relatively small number of the clinical studies
which complied with our selected criteria for inclusion: Namely, those reporting the exact biological
and clinical rationale and detailed information on the irradiation parameters and settings used to
deliver an effective photonic treatment. Nonetheless, we hope that this analysis may contribute to
dissipate the present confusion and uncertainty on this matter and, consequently, make more dental
practitioners confident towards the usage of photonic treatments in periodontics. If this would happen,
it could be foreseen that the demand for more versatile, user-friendly and less expensive light-emitting
instruments specifically designed for oral use could steadily increase, similarly to what is happening
in other branches of Medicine. For low-energy photonic treatments, a possible scenario could be
the development of new protocols for supportive treatment of patients with chronic periodontitis based
on portable LED instruments suitable for self-medication and home use, under medical supervision,
capable to reduce the conventional pharmaceutical approaches to inflammation and infection.
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